Comparative study of isovolemic hemodilution with 3% albumin, dextran-40, and prophylactic enoxaparin (LMWH) on thrombus formation at venous microanastomosis in rats

Microsurgery

Volumn 26, Issue 6, 2006, Pages 456-464

  Farina Jr , Jayme A ^a   Piccinato, Carlos E ^a   Campos, Antonio D ^a   Rossi, Marcos A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DEXTRAN 40; ENOXAPARIN; FIBRINOGEN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN ANTITHROMBIN COMPLEX;

ANASTOMOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FREE TISSUE GRAFT; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMODILUTION; HEMOSTASIS; MALE; MICROSURGERY; NONHUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RAT; THROMBOSIS; TREATMENT OUTCOME;

ANASTOMOSIS, SURGICAL; ANIMALS; DEXTRANS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ENOXAPARIN; FEMORAL VEIN; FIBRINOLYTIC AGENTS; HEMODILUTION; INFUSIONS, INTRAVENOUS; MALE; MICROSURGERY; PLASMA SUBSTITUTES; POSTOPERATIVE COMPLICATIONS; RATS; RATS, WISTAR; SERUM ALBUMIN, BOVINE; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 33749262437     PISSN: 07381085     EISSN: 10982752     Source Type: Journal    
DOI: 10.1002/micr.20270     Document Type: Article

References (29)

1. Acland R. Thrombus formation in microvascular surgery: An experimental study of the effects of surgical trauma. Surgery 1973;73:766-771.
2. Hupkens P, Cooley BC. Comparison of arterial and venous patency in a rat model of subendothelium-stimulated thrombosis. Microsurgery 1996;17:226-229.
3. Kroll SS, Schusterman MA, Reece GP, Miller MJ, Evans GR, Robb GL, Baldwin BJ. Timing of pedicle thrombosis and flap loss after free-tissue transfer. Plast Reconstr Surg 1996;98:1230-1233.
4. Lan M, Li XL, Cooley BC, Gould JS. Microvascular salvage procedures with adjuvant antithrombotic therapy for restitution of patency in a rat model. J Reconstr Microsurg 1992;8:201-205.
5. Farina JA Jr, Piccinato CE, Rossi MA, Mazzer N, LLorach-Velludo MA. Effect of isovolemic hemodilution with 3% albumin on thrombus formation at venous microanastomosis in rats. Microsurgery 2002;22:152-157.
6. Klotz U, Kroemer H. Clinical pharmacokinetic considerations in the use of plasma expanders. Clin Pharmacokinet 1987;12:123-135.
7. Gruber UF. Dextran and the prevention of postoperative thromboembolic complications. Surg Clin North Am 1975;55:679-696.
8. Roberts TS, Nelson CL, Barnes CL, Boone DW, Ferris EJ, Holder JL. Low dose of dextran 40 in reconstructive hip surgery patients. Orthopedics 1990;12:797-801.
9. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB. Prevention of venous thromboembolism. Chest 2001;119(Suppl 1):132S-175S.
10. McGarry LS, Thompson D, Weinstein MC, Goldhaber SZ. Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients. Am J Manag Care 2004;10:632-642.
11. Pindur G, Heiden M, Kohler M. Comparison of low molecular weight heparins and unfractionated heparins after successive subcutaneous administration: A randomized controlled study in healthy volunteers. Arzneimittelforschung 1993;43:542-547.
12. Agnelli G, Iorio A, Renga C, Boschetti E, Nenci GG, Ofosu FA, Hirsh J. Prolonged antithrombin activity of low-molecular-weight heparins. Clinical complications for the treatment of thromboembolic diseases. Circulation 1995;92:2819-2824.
13. Abreu MA, Baroza LGV, Rossi MA. Toluidine blue-basic fuchsin stain for glycolmetacrylate embedded tissue. J Histotechnol 1993;16:179-180.
14. Krämer AH, Hertze NR, Beven EG. Intraoperative hemodilution during elective vascular reconstruction. Surg Gynecol Obstet 1979;149:831-836.
15. Mosesson MW. The roles of fibrinogen and fibrin in hemostasis and thrombosis. Semin Hematol 1992;29:177-188.
16. Larcan A, Stoltz JF. Blood hyperviscosity syndromes. Classification and physiopathological understanding. Therapeutic deductions. Ann Med Interne (Paris) 1983;134:395-410.
17. Vara-Thorbeck R, Fernandez-Marcote JAG. Le dextran et l'hémodilution dans la prévention de la thrombo-embolie postopératoire. Acta Chir Belg 1980;4:249-255.
18. Chou G. Use of hemodilution in microsurgery. Chung Hua Cheng Hsing Shao Shang Wai Ko Tsa Chih 1989;5:259-261.
19. Atchabahian A, Masquelet AC. Experimental prevention of free flap thrombosis. II: Normovolemic hemodilution for thrombosis prevention. Microsurgery 1996;17:714-716.
20. Rothkopf DM, Chu B, Bern S, May JW Jr. The effect of dextran on microvascular thrombosis in an experimental rabbit model. Plast Reconstr Surg 1993;92:511-515.
21. Wieslander JB, Dougan P, Stjernquist U, Abert M, Bergentz SE. The influence of dextran and saline solution upon platelet behavior after microarterial anastomosis. Surg Gynecol Obstet 1986;163:256-262.
22. Wiman D, Östrup LT, Eneström S. The effect of dextran on the incidence of thrombosis in microvenous Nakayama ring pin anastomoses. Scand J Plast Reconstr Surg 1979;13:263-268.
23. McCammon AT, Wright JP, Figueroa M, Nielsen VG. Hemodilution with albumin, but not hextend, results in hypercoagulability as assessed by thrombelastography in rabbits: Role oh heparin-dependent serpins and factor VIII complex. Anesth Analg 2002;95:844-850.
24. Messmer KFW. The use of plasma substitutes with special attention to their side effects. World J Surg 1987;11:69-74.
25. Heilmann L, Heitz R, Koch FU, Ose C. Perioperative prevention of thrombosis in cesarean section: Results of a randomized prospective comparative study with 6% hydroxyethyl starch and 0.62 low dose heparin. Z Geburtshilfe Perinatol 1991;195:10-15.
26. Müller R, Musikic P. Hemorheology in surgery-a review. Angiology 1987;38:581-592.
27. Sanfelippo MJ, Suberviola PD, Geimer NF. Development of a von Willebrand-like syndrome after prolonged use of hydroxyethyl starch. Am J Clin Pathol 1987;88:653-655.
28. Ritter EF, Cronan JC, Rudner AM, Serafin D, Klitzman B. Improved microsurgical anatomotic patency with low molecular weight heparin. J Reconstr Microsurg 1998;14:331-336.
29. Malm K, Dahlback B, Arnljots B. Low-molecular-weight-heparin (dalteparin) effectively prevents thrombosis in a rat model of deep arterial injury. Plast Reconstr Surg 2003;111:1659-1666.